TP53 and lung cancer: SNP variation‐associated inflammatory genes identified between COPD and lung cancer may play critical roles in a COPD‐LC transformation; activated nicotinic acetylcholine receptor gene in COPD may cause mutation and down‐regulates the expression of the crucial tumor suppressor gene TP53 and P53‐related signaling pathways, causing lung tumorigenesis.21, 22